These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 7533365
1. Influence of long-term cyclosporine or FK 506 therapy on glucose and lipid metabolism in stable liver graft recipients. Loss M, Winkler M, Schneider A, Brinkmann C, Manns M, Ringe B, Pichlmayr R. Transplant Proc; 1995 Feb; 27(1):1136-9. PubMed ID: 7533365 [No Abstract] [Full Text] [Related]
2. Glucose and lipid metabolism in liver transplant patients under long-term tacrolimus (FK 506) monotherapy. Loss M, Winkler M, Schneider A, Oldhafer K, Manns MP, Pichlmayr R. Transplant Proc; 1996 Apr; 28(2):1006-7. PubMed ID: 8623210 [No Abstract] [Full Text] [Related]
3. Weight gain and lipid profile changes in liver transplant recipients: long-term results of the American FK506 Multicenter Study. Mor E, Facklam D, Hasse J, Sheiner P, Emre S, Schwartz M, Miller C. Transplant Proc; 1995 Feb; 27(1):1126. PubMed ID: 7533363 [No Abstract] [Full Text] [Related]
4. Hyperlipidemia after liver transplantation: long-term results of the FK506/cyclosporine A US Multicenter Trial. US Multicenter Study Group. Abouljoud MS, Levy MF, Klintmalm GB. Transplant Proc; 1995 Feb; 27(1):1121-3. PubMed ID: 7533360 [No Abstract] [Full Text] [Related]
5. Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight. Neal DA, Gimson AE, Gibbs P, Alexander GJ. Liver Transpl; 2001 Jun; 7(6):533-9. PubMed ID: 11443583 [Abstract] [Full Text] [Related]
6. Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion. White M, Haddad H, Leblanc MH, Giannetti N, Pflugfelder P, Davies R, Isaac D, Burton J, Chan M, Azevedo E, Howlett J, Ignaszewski A, Busque S, Cantarovich M, Ferguson R, Genest J, Ross H. J Heart Lung Transplant; 2005 Jul; 24(7):798-809. PubMed ID: 15982605 [Abstract] [Full Text] [Related]
8. The effect of FK506 versus cyclosporine on glucose and lipid metabolism--a randomized trial. Steinmüller TM, Gräf KJ, Schleicher J, Leder K, Bechstein WO, Mueller AR, Dette K, Schulz E, Neuhaus P. Transplantation; 1994 Sep 27; 58(6):669-74. PubMed ID: 7524203 [Abstract] [Full Text] [Related]
12. Long term efficacy of simvastatin in renal transplant recipients treated with cyclosporine or tacrolimus. Imamura R, Ichimaru N, Moriyama T, Shi Y, Namba Y, Nonomura N, Matsumiya K, Toki K, Takahara S, Okuyama A. Clin Transplant; 2005 Oct 27; 19(5):616-21. PubMed ID: 16146552 [Abstract] [Full Text] [Related]
13. Effects of cyclosporin A and FK 506 on lipid metabolism and fibrinogen in kidney transplant recipients. Hohage H, Arlt M, Brückner D, Dietl KH, Zidek W, Spieker C. Clin Transplant; 1997 Jun 27; 11(3):225-30. PubMed ID: 9193847 [Abstract] [Full Text] [Related]
14. Lipoprotein abnormalities in long-term stable liver and renal transplanted patients. A comparative study. Fernández-Miranda C, de la Calle A, Morales JM, Guijarro C, Aranda JL, Gómez-Sanz R, Gómez-Izquierdo T, Larumbe S, Moreno E, Rodicio JL, del Palacio A. Clin Transplant; 1998 Apr 27; 12(2):136-41. PubMed ID: 9575402 [Abstract] [Full Text] [Related]
15. Lipid parameters predicting liver function in patients with cirrhosis and after liver transplantation. Tietge UJ, Boker KH, Bahr MJ, Weinberg S, Pichlmayr R, Schmidt HH, Manns MP. Hepatogastroenterology; 1998 Apr 27; 45(24):2255-60. PubMed ID: 9951906 [Abstract] [Full Text] [Related]
16. Serum cholesterol changes in long-term survivors of liver transplantation: a comparison between cyclosporine and tacrolimus therapy. Charco R, Cantarell C, Vargas V, Capdevila L, Lázaro JL, Hidalgo E, Murio E, Margarit C. Liver Transpl Surg; 1999 May 27; 5(3):204-8. PubMed ID: 10226111 [Abstract] [Full Text] [Related]
17. Lipid, carbohydrate metabolism, and antioxidant status in children after liver transplantation. Wierzbicka A, Pawłowska J, Socha P, Jankowska I, Skorupa E, Teisseyre M, Ismail H, Czubkowski P, Socha J. Transplant Proc; 2007 Jun 27; 39(5):1523-5. PubMed ID: 17580179 [Abstract] [Full Text] [Related]
18. The effect of cyclosporine vs FK 506 on glucose metabolism. Steinmueller T, Konrad T, Jonas S, Tullius S, Bechstein WO, Mueller A, Platz KP, Neumann U, Vicini P, Toffolo G, Cobelli C, Usadel KH, Neuhaus P. Transplant Proc; 1999 Jun 27; 31(1-2):1129-30. PubMed ID: 10083504 [No Abstract] [Full Text] [Related]
19. Lipid metabolic abnormalities after renal transplantation under cyclosporine and prednisone immunosuppression. Castelao AM, Barberá MJ, Blanco A, Fiol C, Griñó JM, Bover J, GilVernet S, Andrés E, Serón D, Castiñeiras MJ. Transplant Proc; 1992 Feb 27; 24(1):96-8. PubMed ID: 1539356 [No Abstract] [Full Text] [Related]
20. Improved attainment of NKF classified lipid target levels after conversion from cyclosporine to tacrolimus in renal graft recipients. Pohanka E, Margreiter R, Sparacino V, Sperschneider H, European Switch to Tacrolimus Study Group. Transplant Proc; 2005 May 27; 37(4):1874-6. PubMed ID: 15919490 [Abstract] [Full Text] [Related] Page: [Next] [New Search]